Month: January 2022

Oculogica Receives FDA Clearance for its Next Generation EyeBOX

Oculogica, a leader in concussion diagnostics, announced that the U.S. Food and Drug Administration (FDA) granted clearance for the Company’s next generation EyeBOX. The EyeBOX is the first objective testing device authorized by the FDA as an aid in the diagnosis of concussion. The EyeBOX performs a test in under 4-minutes, utilizing a proprietary algorithm and machine …

Oculogica Receives FDA Clearance for its Next Generation EyeBOX Read More »

Scroll to Top